Sterling C. Johnson

Active 1994–2026

338
Papers
36,135
Citations
101
h-index
280
i10-index

Citations

Citations per year for Sterling C. Johnson1967: 1 citations1975: 1 citations1988: 2 citations1989: 2 citations1995: 2 citations1996: 8 citations1997: 18 citations1998: 18 citations1999: 24 citations2000: 35 citations2001: 61 citations2002: 57 citations2003: 60 citations2004: 97 citations2005: 130 citations2006: 150 citations2007: 189 citations2008: 183 citations2009: 234 citations2010: 324 citations2011: 290 citations2012: 338 citations2013: 329 citations2014: 322 citations2015: 357 citations2016: 396 citations2017: 394 citations2018: 398 citations2019: 1,102 citations2020: 1,345 citations2021: 1,569 citations2022: 1,456 citations2023: 1,302 citations2024: 2,156 citations2025: 1,551 citations2026: 76 citations1968–1974: no citations, so these years are not shown1976–1987: no citations, so these years are not shown1990–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,970 citing papers, 29.2% of this breakdownChina: 1,887 citing papers, 9.2% of this breakdownUnited Kingdom: 1,666 citing papers, 8.2% of this breakdownGermany: 1,035 citing papers, 5.1% of this breakdownCanada: 875 citing papers, 4.3% of this breakdownSweden: 755 citing papers, 3.7% of this breakdownItaly: 716 citing papers, 3.5% of this breakdownAustralia: 665 citing papers, 3.3% of this breakdownFrance: 655 citing papers, 3.2% of this breakdownSpain: 646 citing papers, 3.2% of this breakdownNetherlands: 600 citing papers, 2.9% of this breakdownSwitzerland: 431 citing papers, 2.1% of this breakdown
0%29.2%Other 22.1%

Fields

  • Medicine50.8%
  • Neuroscience21.4%
  • Biochemistry, Genetics and Molecular Biology15.7%
  • Psychology3.8%
  • Computer Science3.5%
  • Health Professions0.9%
  • Other3.9%

Topics

  • Dementia and Cognitive Impairment Research8.5%
  • Alzheimer's disease research and treatments7.7%
  • Functional Brain Connectivity Studies5.1%
  • Advanced Neuroimaging Techniques and Applications3.4%
  • Gut microbiota and health3.1%
  • Tryptophan and brain disorders2.2%
  • Other70%

Coauthors

All papers

Open in search
  1. Gut microbiome alterations in Alzheimer’s disease

    Authors: , , , , , , , , , , , - Scientific Reports 2017 cited by 2,111

  2. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2024 cited by 768

  3. Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 431

  4. Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - NeuroImage 2019 cited by 539

  5. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

    Authors: , , , , , , , , , , , , , , , - JAMA Neurology 2023 cited by 295

  6. APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

    Authors: , , , , , , , , , , , , , - Nature Medicine 2024 cited by 331

  7. MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain 2020 cited by 396

  8. A generalized form of context-dependent psychophysiological interactions (gPPI): A comparison to standard approaches

    Authors: , , , - NeuroImage 2012 cited by 1,516

  9. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease

    Authors: , , , , , , , , , , - Alzheimer s Research & Therapy 2018 cited by 464

  10. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2017 cited by 665

  11. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samuel N. Lockhart, Anne M. Murray, Katie E. Osborn, Melinda C. Power, Brittani R. Price, Hanneke Rhodius‐Meester, Jacqueline A. Rondeau, Allyson Rosen, Douglas L. Rosene, Julie A. Schneider, Henrieta Scholtzova, C. Elizabeth Shaaban, Nárlon Cássio Boa Sorte Silva, Heather M. Snyder, Walter Swardfager, Aron M. Troen, Susanne J. van Veluw, Prashanthi Vemuri, Anders Wallin, Cheryl L. Wellington, Donna M. Wilcock, Sharon X. Xie, Atticus H. Hainsworth - Alzheimer s & Dementia Translational Research & Clinical Interventions 2019 cited by 446

  12. Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2023 cited by 123

  13. Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys

    Authors: , , , , , , , , , , - Science 2009 cited by 2,289

  14. The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions

    Authors: , , , , , , , , , , , , , - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2017 cited by 317

  15. Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease

    Authors: , , , , , , , , , , , - Brain Communications 2023 cited by 114

  16. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2018 cited by 350

  17. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease

    Authors: , , , , , , , , , , , , , - JAMA Neurology 2016 cited by 251

  18. The Brain Chart of Aging: Machine‐learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2020 cited by 176

  19. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts

    Authors: , , , , , , , , , , , , , , , , - Brain 2022 cited by 128

  20. Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios

    Authors: , , , , , , , , , , - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2022 cited by 90

  21. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys

    Authors: , , , , , - Nature Communications 2014 cited by 729

  22. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18 F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls

    Authors: , , , , , , , , , - Journal of Nuclear Medicine 2018 cited by 262

  23. Alzheimer's disease biomarkers in Black and non‐Hispanic White cohorts: A contextualized review of the evidence

    Authors: , , , , , , , , , , , , - Alzheimer s & Dementia 2021 cited by 103

  24. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease

    Authors: , , , , , , , , , , , , - JAMA Neurology 2015 cited by 415